AD-35

· Zhejiang Hisun Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-35, covering 2020-03-25 to 2020-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]